Table 1

Patient’s background characteristics

FactorN
Total59
Age
 55–599
 60–6933
 70–7917
T
 257
 32
N
 043
 116
Clinical stage
 IIA43
 IIB14
 IIIA2
ER
 +59
 −0
PgR
 +55
 −4
HER2
 +0
 −59
Adjuvant chemotherapy
 +18
 −41
  • ER, oestrogen receptor;HER2, human epidermal growth factor receptor 2; PgR, progesterone receptor.